Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Tigenix november 2017

436 Posts
Pagina: «« 1 ... 17 18 19 20 21 22 »» | Laatste | Omlaag ↓
  1. TheBateman 27 november 2017 00:23
    The Group directors concluded that the significant influence over its TiGenix investment has
    ceased. The facts that lead to that conclusion are the resignation of its preferred rights to
    distribute the main drug under investigation by TiGenix and the fact that Grifols Group has no
    longer appointed board members and do not expect to have any. Additionally it has been
    considered the fact that the time needed for exercising its right of appointment of one board
    director is too long as to allow Grifols to participate in the board decisions in due time.
    As a consequence the investment in TiGenix has been reclassified to Available for Sale Financial
    Assets. The effect of this reclassification resulted in a revaluation of the investment at fair value
    and the related gain amounting to Euros 24 million has been accounted for in Share of
  2. [verwijderd] 27 november 2017 00:43
    quote:

    four60 schreef op 26 november 2017 15:26:

    Ik heb een flinke pluk Tigenix en ga voor de langere termijn belegging tenzij ze worden overgenomen.
    Eens. Zo zie ik het ook.
    Er zijn gewoon zeer veel en zwaarwegende tekenen en feiten dat er een mooie toekomst is op de korte en op de wat langere termijn.

  3. Bio-marker 27 november 2017 08:39
    quote:

    TheBateman schreef op 27 november 2017 00:23:

    The Group directors concluded that the significant influence over its TiGenix investment has
    ceased. The facts that lead to that conclusion are the resignation of its preferred rights to
    distribute the main drug under investigation by TiGenix and the fact that Grifols Group has no
    longer appointed board members and do not expect to have any. Additionally it has been
    considered the fact that the time needed for exercising its right of appointment of one board
    director is too long as to allow Grifols to participate in the board decisions in due time.
    As a consequence the investment in TiGenix has been reclassified to Available for Sale Financial
    Assets. The effect of this reclassification resulted in a revaluation of the investment at fair value
    and the related gain amounting to Euros 24 million has been accounted for in Share of
    Dank hiervoor. Wat is bron en datum?
  4. Semper Nescio 27 november 2017 10:12
    quote:

    TheBateman schreef op 27 november 2017 00:23:

    The Group directors concluded that the significant influence over its TiGenix investment has
    ceased. The facts that lead to that conclusion are the resignation of its preferred rights to
    distribute the main drug under investigation by TiGenix and the fact that Grifols Group has no
    longer appointed board members and do not expect to have any. Additionally it has been
    considered the fact that the time needed for exercising its right of appointment of one board
    director is too long as to allow Grifols to participate in the board decisions in due time.
    As a consequence the investment in TiGenix has been reclassified to Available for Sale Financial
    Assets. The effect of this reclassification resulted in a revaluation of the investment at fair value
    and the related gain amounting to Euros 24 million has been accounted for in Share of
    Kun je even een link naar het volledige artikel bezorgen? Zou graag eens het volledige artikel lezen.
  5. forum rang 4 Rider 27 november 2017 12:05
    quote:

    whoiam schreef op 27 november 2017 11:52:

    ik zit nog niet in tigenix, maar lees nu de laatste dagen dit forum, lijkt me een goed inkoopmoment met veel potentieel? ben aan het twijfelen voor deel kiadis te verkopen en deel tigenix te kopen, wat denken jullie?
    Ik zit in beide. Heb wel dubbel zoveel Kiadis als Tigenix.
  6. forum rang 6 posilies 27 november 2017 12:08
    quote:

    TheBateman schreef op 27 november 2017 00:23:

    The Group directors concluded that the significant influence over its TiGenix investment has
    ceased. The facts that lead to that conclusion are the resignation of its preferred rights to
    distribute the main drug under investigation by TiGenix and the fact that Grifols Group has no
    longer appointed board members and do not expect to have any. Additionally it has been
    considered the fact that the time needed for exercising its right of appointment of one board
    director is too long as to allow Grifols to participate in the board decisions in due time.
    As a consequence the investment in TiGenix has been reclassified to Available for Sale Financial
    Assets. The effect of this reclassification resulted in a revaluation of the investment at fair value
    and the related gain amounting to Euros 24 million has been accounted for in Share of
    Niet zo positief
436 Posts
Pagina: «« 1 ... 17 18 19 20 21 22 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 887,44 +0,99%
EUR/USD 1,0762 0,00%
FTSE 100 8.213,49 +0,51%
Germany40^ 18.017,10 +0,67%
Gold spot 2.301,75 0,00%
NY-Nasdaq Composite 16.156,33 +1,99%

Stijgers

Umicore
+6,53%
IBA
+4,89%
SYENSQO
+4,27%
Proximus
+3,65%
Barco
+3,53%

Dalers

bpost
-5,07%
Aperam
-4,56%
Ontex
-2,47%
Kinepolis
-2,08%
Galapagos
-1,32%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links